HCM

Quote

Short

News

Articles

Message Board

HUTCHMED (China) Limited (NASDAQ : HCM ) News

HUTCHMED (China) Limited (NASDAQ: HCM) News Releases

HCM News Releases

May 28, 2026 06:15:03 pm

KlickAnalytics

HCM Price Target Alert: $13.60. Issued by Morgan Stanley

May 21, 2026 08:00:00 pm

GlobeNewswire

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

May 21, 2026 06:00:00 am

GlobeNewswire

HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

April 29, 2026 08:35:00 am

GlobeNewswire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

April 29, 2026 06:00:00 am

GlobeNewswire

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

April 23, 2026 08:35:00 am

GlobeNewswire

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026

April 08, 2026 08:00:00 pm

GlobeNewswire

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026

March 22, 2026 08:00:00 pm

GlobeNewswire

HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China

March 09, 2026 05:30:00 am

GlobeNewswire

HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China

March 06, 2026 03:30:00 am

GlobeNewswire

Intended Retirement of Independent Non-executive Director and changes of composition of board committees

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account